Table 2 Clinical trials of aryl sulfonamides.
From: RNA-binding protein 39: a promising therapeutic target for cancer
Type | NCT Number | Condition | Phase | Start Date |
|---|---|---|---|---|
Indisulam | NCT00165594 | Gastric cancer | Phase 1, Phase 2 | February 2005 |
NCT00165867 | Colorectal cancer | Phase 2 | April 2005 | |
NCT01692197 | Leukemia | Phase 2 | February 2013 | |
NCT00059735 | Kidney Neoplasms, Carcinoma, Adenocarcinoma, | Phase 2 | May 2002 | |
NCT00165880 | Breast Cancer | Phase 2 | December 2004 | |
NCT00165854 | Colorectal cancer | Phase 2 | March 2003 | |
NCT00014625 | Melanoma (Skin) | Phase 2 | February 2001 | |
NCT00080197 | Breast neoplasms | Phase 2 | February 2004 | |
E7820 | NCT01133990 | Colorectal cancer | Phase 1, Phase 2 | April 2010 |
NCT00309179 | Advanced colorectal cancer | Phase 2 | September 2007 | |
NCT00078637 | Malignant neoplasms, lymphoma | Phase 1 | January 2004 | |
NCT01347645 | Colon cancer, Rectal cancer | Phase 1, Phase 2 | September 2011 | |
NCT01773421 | Advanced solid tumors | Phase 1 | June 2011 | |
CQSC | NCT00005864 | Colorectal cancer | Phase 2 | April 2000 |
NCT00008372 | Lung cancer | Phase 2 | December 2000 | |
Tasisulam | NCT01215916 | Solid tumors | Phase 1 | February 2008 |
NCT01258348 | Metastatic renal cell cancer | Phase 1 | July 2008 | |
NCT01214668 | Solid tumors | Phase 1 | January 2009 | |
NCT00383292 | Metastatic melanoma | Phase 2 | November 2006 | |
NCT00992225 | Breast cancer | Phase 2 | September 2009 | |
NCT00363766 | Non-small-cell lung Cancer | Phase 2 | September 2006 | |
NCT01284335 | Advanced solid tumors | Phase 1 | July 2008 | |
NCT01006252 | Melanoma | Phase 3 | December 2009 | |
NCT00718159 | Acute myeloid leukemia | Phase 1 | August 2008 | |
NCT01185548 | Lymphoma, Advanced cancer | Phase 1 | July 2010 | |
NCT00490451 | Sarcoma, Soft tissue | Phase 2 | August 2007 | |
NCT00428610 | Ovarian, Fallopian tube, Primary peritoneal cancer | Phase 2 | February 2007 |
